Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.
about
Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participantsAge at development of type 1 diabetes- and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth.Prediction of type 1 diabetes in the general population.The pancreas in human type 1 diabetes.Dietary intervention in infancy and later signs of beta-cell autoimmunityAge of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.Strategies for the prevention of autoimmune type 1 diabetesPredictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).Etiopathogenesis of insulin autoimmunity.The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial-type 1.Reduced β-cell function in early preclinical type 1 diabetesAnalyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunityECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patientsCord serum lipidome in prediction of islet autoimmunity and type 1 diabetesPatterns of β-cell autoantibody appearance and genetic associations during the first years of life.Autoimmunity against INS-IGF2 protein expressed in human pancreatic islets.Influence of type 1 diabetes genes on disease progression: similarities and differences between countries.Increasing ICA512 autoantibody titers predict development of abnormal oral glucose tolerance tests.Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?Role of humoral beta-cell autoimmunity in type 1 diabetes.Maternal dietary fatty acid intake during pregnancy and the risk of preclinical and clinical type 1 diabetes in the offspring.The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients.Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child.Predictors of slow progression to diabetes in children with multiple islet autoantibodies.Validation of molecular and genomic biomarkers of retinal drug efficacy: use of ocular fluid sampling to evaluate VEGF.Islet cell antibodies (ICA) identify autoimmunity in children with new onset diabetes mellitus negative for other islet cell antibodies.Clinical and biochemical features at diagnosis of type 1 diabetes in patients between 0 and 18 years of age from Jordan.Exocrine pancreas function decreases during the progression of the beta-cell damaging process in young prediabetic children.Early life origin of type 1 diabetes.Maternal VDR variants rather than 25-hydroxyvitamin D concentration during early pregnancy are associated with type 1 diabetes in the offspring.Predicting progression to diabetes in islet autoantibody positive children.Class II HLA Genotype Association with First Phase Insulin Response Is Explained by Islet Autoantibodies.Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis.Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances.
P2860
Q30557549-637B4952-AE3D-4B4F-8CE1-419DBE6388D2Q33751495-B1F509FA-F2BE-4002-A81B-1E794E844C0CQ33873033-8D87C0B5-DD3B-4794-82B8-107A3645E237Q34496850-A7A45229-B417-4AC8-B15C-B29519636263Q34567034-C71761D0-937E-4FFA-8F75-C33E03E6811FQ35043330-9B10DC7D-7BB2-4D00-A655-0D0BAA14E07FQ35116303-09F41F93-61A0-4CCC-84CE-F1A276962758Q35227148-2C526734-18B1-4C91-9E22-3F75D0BA237EQ35502154-E9967429-904B-402C-9DAC-C401029D6636Q35531906-0B06A60C-EAC3-4D87-A103-27929E000237Q35910119-087268DE-2A46-41AE-9E83-62374D4A6A95Q35976782-00565483-C41C-4737-A7E6-453A658BF59AQ36461183-106C7437-0D5C-4CAA-9DEF-11B730566A1EQ36762700-A4F20C65-DFD8-4A18-8A38-034EC9C043D0Q37022756-EA8EF166-B91F-489D-AD71-2B20F2A5F36EQ37062268-EC9FE9DA-C181-423A-98E3-2C42E50BACB2Q37106456-CCC09A81-EEDB-42D2-990D-CD89A3C86771Q37110596-A5D9F902-515B-4495-B4CF-57AF1BB281ACQ37193363-EE41F949-9A3D-4437-B218-853054A0C05AQ37213887-2F8BD168-DE62-4304-ADA5-7DF6677EA114Q38034937-D25C6682-62D6-41D1-9F71-64BD7694FF8FQ38679602-EE10FBA0-AF7F-43B6-AC4F-4B42F8809829Q38734604-484966C2-C1BE-4726-81B4-5E051BE44302Q38837965-BF076569-1888-430D-BA3E-8E97D09A0AEAQ38842309-6B86DBFE-6052-492F-B487-872EE45B6B38Q39304710-0C585E40-FCD1-429B-B4F9-4EC873FC5A00Q40735953-5D376AC5-9C52-46CA-9E1C-8233F6EF9F0BQ42370198-CC72C104-1F03-4055-ABA8-B62321766353Q42407419-B5A5FBB9-6F95-4CAD-ADB1-4E2DDD790E3FQ43731070-4D70FB3E-AA24-486D-9F8F-7F42C4AAEDCFQ46115645-F1925ABB-C0E8-4455-8D18-F523783D28DDQ47245204-620771EB-1B07-46FF-B330-62C409E02484Q47608755-45B068D0-8E86-42CB-ABB3-E3E67F039A72Q48244211-E1B793D2-291B-4D8E-943B-A35B4C9F45BAQ48786260-564C8075-997E-479A-A783-8D3A9AFA1170Q50066962-5D582588-E5F5-4629-AA5F-E2B9521DACBEQ50120159-7A7F2CA9-1C71-4B74-963D-8AB638E67FCBQ50950195-228EC03A-0C5A-4C07-901C-11CE03E3EABCQ51302837-D7B9FD6B-1C5F-4AB2-A4E7-6413D19059C8Q52655231-3212DAB5-55A5-48A3-8309-0BBC3E8BA684
P2860
Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predictive characteristics of ...... ity in the general population.
@en
Predictive characteristics of ...... ity in the general population.
@nl
type
label
Predictive characteristics of ...... ity in the general population.
@en
Predictive characteristics of ...... ity in the general population.
@nl
prefLabel
Predictive characteristics of ...... ity in the general population.
@en
Predictive characteristics of ...... ity in the general population.
@nl
P2093
P2860
P356
P1433
P1476
Predictive characteristics of ...... ity in the general population.
@en
P2093
Anne Hekkala
Heli T A Siljander
Jorma Ilonen
Jyrki Lähde
Olli Simell
Paula Vähäsalo
Satu Simell
Tuula Simell
P2860
P304
P356
10.2337/DB08-1305
P407
P577
2009-09-15T00:00:00Z